Skip to main content

Naomi B Haas

NIH Rank #13679
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1877669Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$740K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#13,679
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Naomi B Haas. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$740K

1 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Naomi B Haas as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA308071-01R01
    Optimizing neoadjuvant/adjuvant anti-PD-1 therapy for localized Renal Cell Carcinoma
    $740K
    award amount

Award organization

Organizations that administered FY2026 awards listing Naomi B Haas as a PI.

FY2026 award administered by Brigham and Women's Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2025
    $500K Cumulative Funding
  3. 2025
    R01 Grant Holder
  4. 2026
    $1M Cumulative Funding